SureTrader Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Inovio Pharmaceuticals, Inc. (INO)

INO RSS Feed
Add INO Price Alert      Hide Sticky   Hide Intro
Moderator: nanopatent, TomP1
Search This Board:
Last Post: 4/29/2016 4:33:31 PM - Followers: 408 - Board type: Free - Posts Today: 0

Logo: Inovio

www.inovio.com/

http://finance.yahoo.com/q/ks?s=INO

http://finance.aol.com/company/inovio-biomedical-corporation/ino/ase/institutional-ownership

F
ebruary 12, 2014 Inovio CEO Dr. Joseph Kim rings bell to open trading on NYSE- http://www.youtube.com/watch?v=95yO6hFpbUM


Float: 97.65 M

Shares Outstanding: 127.26 M


Inovio Biomedical Corporation engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The company?s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against evolving, unmatched strains of pathogens, such as influenza. Inovio?s proprietary electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. The company also has access to formulation and manufacturing expertise, and technology through its controlling ownership in VGX International. Inovio?s clinical programs include trials for HPV/cervical cancer (therapeutic) and HIV vaccines; and an IND has been filed for an avian influenza vaccine. Its partners and collaborators include Roche,Merck, Tripep, University of Southampton, University of Pennsylvania, HIV Vaccines Trial Network, and National Microbiology Laboratory of the Public Health Agency of Canada. The company was formerly known as Genetronics Biomedical Corp. and changed its name to Inovio Biomedical Corporation in March 2005. The company was founded in 1983 and is based in San Diego, California.

Currently Inovio has 12 clinical studies ( HIV, Influenza, Malaria, Hepatitis B, Hepatitis C, Breast and Lung cancer, Prostate Cancer, Head and Neck cancer, Cervical Cancer, Cervical dysplasia caused by HPV) ongoing from preclinical to phase 2.
 
Sep 10, 2013
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products. Roche will make an upfront payment of USD $10 million to Inovio. Roche will also provide preclinical R&D support and payments for near-term regulatory milestones as well as payments upon reaching certain development and commercial milestones potentially up to USD $412.5 million. Additional development milestone payments could also be made to Inovio if Roche pursues other indications with INO-5150 or INO-1800.  In addition, Inovio is entitled to receive up to double-digit tiered royalties on product sales.

VGX-3100-Phase 2 Clinical Trial initiated for the treatment Cervical dysplasia (cervical intraepithelial neoplasia or CIN) caused by HPV
Top line data release Mid 2014
May 13, 2014:  Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis
http://finance.yahoo.com/news/inovio-pharmaceuticals-acquires-early-stage-080000624.html?.tsrc=applewf

May 23, 2014: Inovio Pharmaceuticals Announces 1 For 4 Reverse Split
http://finance.yahoo.com/news/inovio-pharmaceuticals-announces-1-4-080000629.html
1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.


Inovio’s goal is to revolutionize vaccines. With best-in-class immune responses from multiple vaccines in different disease areas, our synthetic vaccine technology is making big strides toward this important goal.



 
 



 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
INO
Current Price
Volume:
Bid Ask Day's Range
Wiki
SureTrader
PostSubject
#4698  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 08/02/13 01:15:33 PM
#13367   * * $INO Video Chart 04-29-16 * * ClayTrader 04/29/16 04:33:31 PM
#13366   Good answer Nanopatent! Pipilongstocking 04/29/16 03:15:47 PM
#13365   Merck and Roche are in a battle for control? nanopatent 04/29/16 12:09:20 PM
#13364   Why? ppnlf 04/29/16 11:45:26 AM
#13363   I'm not sophisticated!! nanopatent 04/29/16 09:02:01 AM
#13362   Did you do dollar cost averaging and buy cadillac107 04/29/16 08:58:52 AM
#13361   I know what you mean!! nanopatent 04/29/16 08:47:36 AM
#13360   Careful about making price predictions, especially with unseasoned cadillac107 04/28/16 09:42:27 PM
#13359   * * $INO Video Chart 04-28-16 * * ClayTrader 04/28/16 04:46:49 PM
#13358   Pennsylvania’s Inovio Pharma (INO) Doubles Workforce, Continues Hiring Spree nanopatent 04/28/16 02:56:52 PM
#13357   How high will INO fly? nanopatent 04/28/16 01:14:57 PM
#13356   * * $INO Video Chart 04-27-16 * * ClayTrader 04/27/16 04:34:11 PM
#13355   boom! harry crumb 04/27/16 04:17:19 PM
#13354   Inovio = the Google of medicine. nanopatent 04/27/16 02:54:41 PM
#13353   Inovio Partners with National Cancer Institute and Mayo nanopatent 04/27/16 02:42:15 PM
#13352   * * $INO Video Chart 04-25-16 * * ClayTrader 04/25/16 04:33:19 PM
#13351   * * $INO Video Chart 04-22-16 * * ClayTrader 04/22/16 04:57:16 PM
#13350   * * $INO Video Chart 04-21-16 * * ClayTrader 04/21/16 05:05:06 PM
#13349   http://www.secinfo.com/d1z6V1.w1a.htm nanopatent 04/18/16 04:58:25 PM
#13348   * * $INO Video Chart 04-18-16 * * ClayTrader 04/18/16 04:58:00 PM
#13347   Can you link to an SEC filling plezse TomP1 04/18/16 04:36:51 PM
#13346   Over $10! nanopatent 04/18/16 03:17:10 PM
#13345   $$$$$ Tdash 04/18/16 03:03:08 PM
#13344   the entire 1 year gap has been filled! harry crumb 04/18/16 02:52:44 PM
#13343   insider buys! next leg up over 10! harry crumb 04/18/16 02:45:51 PM
#13342   And why is Inovio not getting the respect nanopatent 04/15/16 05:13:56 PM
#13341   Yes. Honestly I was surprised by that. Animal pmgtrader 04/15/16 05:05:18 PM
#13340   Just for emphasis - it doesn't get any nanopatent 04/15/16 05:02:40 PM
#13339   Abstract Number: LB-253 Presentation Title: Control of tumor growth in vivo pmgtrader 04/15/16 04:37:10 PM
#13335   Here is the Roche deal: nanopatent 04/15/16 09:13:02 AM
#13334   I looked at the short position and the Paulness 04/14/16 08:07:21 PM
#13332   INO Roche terminated its short employment of INO. MiamiGent 04/14/16 05:46:40 PM
#13331   Sean Parker donates 250 million towards advancing Immunotherapy future1 04/14/16 10:30:36 AM
#13330   Now we are moving in the right direction gfunk15 04/14/16 10:21:45 AM
#13329   CDC: Zika virus worse then thought sweet crude 04/12/16 02:48:43 PM
#13328   Analysts: Inovio Pharmaceuticals, Inc. (INO) Stock Could Go nanopatent 04/12/16 02:32:13 PM
#13327   Is he gonna get it? Read somewhere they TomP1 04/12/16 04:56:45 AM
#13326   Per CBS Evening News, Obama asks for $1.9 north40000 04/11/16 06:43:00 PM
#13325   Up front! nanopatent 04/06/16 04:00:50 PM
#13324   All that cash ?? Please explain. TomP1 04/06/16 03:18:01 PM
#13323   I figure with all that cash big pharma nanopatent 04/06/16 02:51:47 PM
#13322   How about have the end of p2 meeting TomP1 04/06/16 01:54:14 PM
#13321   INO needs VGX-3100 HPV Cervical Dysplasia to complete Silvr Surfr 04/06/16 01:43:17 PM
#13320   Who knows whats comming. Preaty useless to speculate TomP1 04/05/16 05:46:01 AM
#13319   14-15 coming! harry crumb 04/04/16 06:24:24 PM
#13318   agree 100% harry crumb 04/04/16 10:14:06 AM
#13317   Double figures are imminent. nanopatent 04/04/16 09:06:28 AM
#13316   10 mayb today! harry crumb 04/04/16 06:11:31 AM
#13315   should see 10 next week! harry crumb 04/02/16 12:42:10 AM
#13314   what a great looking chart with ino! harry crumb 04/02/16 12:41:20 AM
PostSubject